Featured Post

IU administering, leading clinical research on FDA-approved Alzheimer’s drug

For nearly a decade, lecanemab has been tested in clinical trials at IU School of Medicine. The drug targets the removal of amyloid plaques in the brain—a hallmark of Alzheimer’s disease. Over the past few months, nearly a dozen patients have received the treatment, which is administered through intravenous infusions every two weeks at the IU Health Neuroscience Center in downtown Indianapolis.

Ben Middelkamp  |  Nov 13, 2023

Read this story

portrait of jason allen

A new era for radiology at IU

A new era began for the Department of Radiology and Imaging Sciences at Indiana University School of Medicine this fall with the arrival of new

Sonder Collins  |  Nov 10, 2023

Kate Foley holds her award and stands with other faculty members

Neurology postdoctoral scholar awarded first Alzheimer's Association Perelman Fellowship

The Alzheimer’s Association recently named Kate Foley, PhD, postdoctoral fellow in the Department of Neurology at Indiana University School of Medicine, as the inaugural Dr.

Ben Middelkamp  |  Oct 20, 2023

Cristian Lasagna-Reeves speaks at AAIC

IU School of Medicine scientists produce world's 'most impactful' Alzheimer's research

Cristian Lasagna-Reeves, PhD, received an award at the 2023 Alzheimer’s Association International Conference for the “most impactful study published in Alzheimer’s research.” IU School of

Laura Gates  |  Jul 19, 2023

Andrew Saykin, PsyD

Fighting Alzheimer's: Saykin leads team science initiatives to stop progression of dementia

Since joining IU School of Medicine, Andrew Saykin, PsyD, has received $53.6 million in NIH funding for research on Alzheimer's and other neurological disorders. He

Laura Gates  |  Jul 07, 2023

Parker Joseph Schroll

Parker Schroll memorial fund to support brain injury research at IU School of Medicine

Grandparents established the Parker Joseph Schroll Traumatic Brain Injury Fund at IU School of Medicine to support research, education and clinical care in TBI through

Laura Gates  |  May 30, 2023

Lauren Hirschfeld in cap and gown

2023 PhD grad hopes to 'be part of a big win' in neurodegenerative disease

Lauren Hirschfeld, PhD, spoke at the Class of 2023 commencement ceremony May 8. Her advice to graduates: "Never stop asking, 'Why?'"

Laura Gates  |  May 08, 2023

Bruce Lamb portrait

IU Distinguished Professor Bruce Lamb: A humble, visionary leader in Alzheimer's research

Bruce Lamb, PhD, nationally recognized research scientist in Alzheimer’s disease and executive director of the Stark Neurosciences Research Institute, is now an Indiana University Distinguished

Laura Gates  |  Apr 05, 2023

Lamb named IU Distinguished Professor

Indiana University has named Bruce T. Lamb, PhD a Distinguished Professor, the university’s highest academic title. He was one of four faculty to receive the

Ben Middelkamp  |  Feb 15, 2023